Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calvin Lee

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Gastrointestinal Endoscopy|October 31, 2024
American Society for Gastrointestinal Endoscopy clinical practice guideline development policy and checklist, Nirav C Thosani, , et al.
Blood Advances|March 14, 2025
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX studyBei Hu, Patrick M Reagan, Laurie H Sehn, et al.
Blood Advances|March 15, 2025
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomesMarek Trněný, Laura Maria Fogliato, Faithlore Gardner, et al.
Gastrointestinal Endoscopy|July 1, 2026
Adverse events associated with endoscopic retrograde cholangiopancreatography (ERCP) and ERCP-related procedures, Nauzer Forbes, Monica Saumoy, et al.
Gastrointestinal Endoscopy|June 29, 2021
Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexityAdam Slivka, Andrew S Ross, Divyesh V Sejpal, et al.
Blood|February 26, 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 studyJoshua F Zeidner, David A Sallman, Christian Récher, et al.
Blood|January 10, 2023
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trialYuqin Song, Hervé Tilly, Shinya Rai, et al.
The New England Journal of Medicine|December 14, 2021
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell LymphomaHervé Tilly, Franck Morschhauser, Laurie H Sehn, et al.
Blood|September 25, 2025
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX studyCarrie Thompson, Marek Trněný, Franck Morschhauser, et al.
Translational Psychiatry|May 12, 2023
CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and miceSandra Sanchez-Roige, Mariela V Jennings, Hayley H A Thorpe, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Gastrointestinal Endoscopy|October 31, 2024
American Society for Gastrointestinal Endoscopy clinical practice guideline development policy and checklist, Nirav C Thosani, , et al.
Blood Advances|March 14, 2025
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX studyBei Hu, Patrick M Reagan, Laurie H Sehn, et al.
Blood Advances|March 15, 2025
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomesMarek Trněný, Laura Maria Fogliato, Faithlore Gardner, et al.
Gastrointestinal Endoscopy|July 1, 2026
Adverse events associated with endoscopic retrograde cholangiopancreatography (ERCP) and ERCP-related procedures, Nauzer Forbes, Monica Saumoy, et al.
Gastrointestinal Endoscopy|June 29, 2021
Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexityAdam Slivka, Andrew S Ross, Divyesh V Sejpal, et al.
Blood|February 26, 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 studyJoshua F Zeidner, David A Sallman, Christian Récher, et al.
Blood|January 10, 2023
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trialYuqin Song, Hervé Tilly, Shinya Rai, et al.
The New England Journal of Medicine|December 14, 2021
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell LymphomaHervé Tilly, Franck Morschhauser, Laurie H Sehn, et al.
Blood|September 25, 2025
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX studyCarrie Thompson, Marek Trněný, Franck Morschhauser, et al.
Translational Psychiatry|May 12, 2023
CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and miceSandra Sanchez-Roige, Mariela V Jennings, Hayley H A Thorpe, et al.
Pageof 7